2024 ESC Guidelines for the management of atrial fibrillation (Translation of the shortened document prepared by the Czech Heart Rhythm Association of the Czech Society of Cardiology)

Lucie Šedivá, Robert Čihák, Štěpán Havránek, Martin Fiala, Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, De Potter TJR, Dwight J, Guasti L, Hanke T, Jaarsma T, Lettino M, Løchen ML, Lumbers RT, Maesen B, Mølgaard I, Rosano GMC, Sanders P, Schnabel RB, Suwalski P, Svennberg E, Tamargo J, Tica O, Traykov V, Tzeis S, Kotecha D

Cor Vasa 2025, 67(2):95-134 | DOI: 10.33678/cor.2025.041  

2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (Translation of the summary of the document prepared by the Czech Society of Angiology, 2025)

Debora Karetová, Miroslav Chochola, Jana Hirmerová, Jiří Matuška, Jan Piťha, Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, Bura-Rivière A, De Backer J, Deglise S, Della Corte A, Heiss C, Kałużna-Oleksy M, Kurpas D, McEniery CM, Mirault T, Pasquet AA, Pitcher A, Schaubroeck HAI, Schlager O, Sirnes PA, Sprynger MG, Stabile E, Steinbach F, Thielmann M, van Kimmenade RRJ, Venermo M, Rodriguez-Palomares JF

Cor Vasa 2025, 67(2):135-181 | DOI: 10.33678/cor.2025.050  

2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (Translation of the shortened document prepared by the Czech Society of Cardiology)

Pavel Procházka, Petr Vařejka, Jiří Matuška, Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, Bura-Rivière A, De Backer J, Deglise S, Della Corte A, Heiss C, Kałużna-Oleksy M, Kurpas D, McEniery CM, Mirault T, Pasquet AA, Pitcher A, Schaubroeck HAI, Schlager O, Sirnes PA, Sprynger MG, Stabile E, Steinbach F, Thielmann M, van Kimmenade RRJ, Venermo M, Rodriguez-Palomares JF

Cor Vasa 2025, 67(2):182-229 | DOI: 10.33678/cor.2025.051  

2024 ESC Guidelines for the management of chronic coronary syndromes (Translation of the shortened document prepared by the Czech Interventional Cardiology Association of the Czech Society of Cardiology)

Petr Kala, Radek Pudil, Ivo Varvařovský, Hana Skalická, Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, Chieffo A, Christodorescu RM, Deaton C, Doenst T, Jones HW, Kunadian V, Mehilli J, Milojevic M, Piek JJ, Pugliese F, Rubboli A, Semb AG, Senior R, ten Berg JM, Van Belle E, Van Craenenbroeck EM, Vidal-Perez R, Winther S

Cor Vasa 2025, 67(2):230-294 | DOI: 10.33678/cor.2025.052  

Myocardial infarction in a young patient with antiphospholipid syndrome: A case report

Marta Catarina Bernardo, Catarina Ribeiro Carvalho, Catarina Ferreira, Inês Silveira, Ana Batista, Sofia Silva Carvalho, Ilídio Moreira

Cor Vasa 2025, 67(2):302-304 | DOI: 10.33678/cor.2024.085  

This case report highlights the importance of a multimodal approach, tailored therapeutic interven- tions, and the poor prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA) in a young patient with antiphospholipid syndrome (APS). A 39-year-old man was admitted with a diagnosis of a ST elevation myocardial infarction (STEMI), in Killip class III. Angiography showed absence of obstructive epicardial coronary artery disease prompting further evaluation with cardiac magnetic resonance imaging (MRI). It revealed infarction scars in multiple arterial territories and severe left ventricular dysfunction. The patient evolved with...

(Current treatment options of pulmonary arterial hypertension in the Czech Republic, its limitations and perspectives, update of the therapeutic algorithm for pulmonary arterial hypertension. Expert consensus statement of the Working Group on Pulmonary Circulation of the Czech Society of Cardiology)

Pavel Jansa, David Ambrož, Marián Felšőci, Lucie Miksová, Jan Přeček, Hikmet Al-Hiti, Radek Pudil, Martin Hutyra

Cor Vasa 2025, 67(2):295-300 | DOI: 10.33678/cor.2025.046  

Pulmonary hypertension is defined as a syndrome characterized by an increase of the mean pulmonary artery pressure >20 mmHg. Pulmonary arterial hypertension (PAH) is a rare disease that accounts for approximately 1% of all cases of chronic pulmonary hypertension. In the pathophysiology, the key factor is initially vasoconstriction, followed by remodeling of pulmonary arterioles, accompanied by an increase of pulmonary vascular resistance and the right ventricle chronic pressure overload. In the treatment of PAH, medical therapy is dominant. Patients with a positive vasoreactivity testing are indicated for treatment with high doses of calcium channel...

Filip Dosbaba, Ladislav Baťalík, Kateřina Filáková a kolektiv: Kardiovaskulární rehabilitace a prevence

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2025, 67(2):316  

Sto let od narození profesora Jiřího Widimského

Prof. MUDr. Jiří Widimský Jr., CSc.

Cor Vasa 2025, 67(2):307-309  

Opustila nás prof. MUDr. Lenka Špinarová, Ph.D., FESC (6. 8. 1961-11. 4. 2025)

Prof. MUDr. Jiří Vítovec, CSc.; prof. MUDr. Jan Krejčí, Ph.D.

Cor Vasa 2025, 67(2):310-311  

Významné jubileum paní profesorky Cífkové

Michael Aschermann

Cor Vasa 2025, 67(2):312-313  

Ludmila Klímová slaví životní jubileum

Michael Aschermann

Cor Vasa 2025, 67(2):314  

Profesor Josef Veselka oslaví šedesáté narozeniny

Michael Aschermann

Cor Vasa 2025, 67(2):315